MMSI Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 8.48% compared to Merit Medical Systems's net margin of 14.45%. Merit Medical Systems's return on equity of 9.19% beat Boston Scientific's return on equity of 9.57%.

Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 16.09%. On the other hand Boston Scientific has an analysts' consensus of $117.55 which suggests that it could grow by 10.34%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.

Merit Medical Systems has a beta of 0.662, which suggesting that the stock is 33.793% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.681, suggesting its less volatile than the S&P 500 by 31.908%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Merit Medical Systems's net income of $30.1M is lower than Boston Scientific's net income of $674M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.83x while Boston Scientific's PE ratio is 77.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.04x versus 9.04x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

ICU Medical has a net margin of 8.48% compared to Merit Medical Systems's net margin of -2.56%. Merit Medical Systems's return on equity of 9.19% beat ICU Medical's return on equity of -4.64%.

Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 16.09%. On the other hand ICU Medical has an analysts' consensus of $186.20 which suggests that it could grow by 41.25%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.662, which suggesting that the stock is 33.793% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.881, suggesting its less volatile than the S&P 500 by 11.918%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ICU Medical quarterly revenues of $604.7M. Merit Medical Systems's net income of $30.1M is higher than ICU Medical's net income of -$15.5M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.83x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.04x versus 1.33x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

Integer Holdings has a net margin of 8.48% compared to Merit Medical Systems's net margin of -5.14%. Merit Medical Systems's return on equity of 9.19% beat Integer Holdings's return on equity of 4.85%.

Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 16.09%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 21.37%. Given that Integer Holdings has higher upside potential than Merit Medical Systems, analysts believe Integer Holdings is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.662, which suggesting that the stock is 33.793% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.979, suggesting its less volatile than the S&P 500 by 2.088%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Integer Holdings quarterly revenues of $437.4M. Merit Medical Systems's net income of $30.1M is higher than Integer Holdings's net income of -$22.5M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.83x while Integer Holdings's PE ratio is 58.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.04x versus 2.47x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 8.48% compared to Merit Medical Systems's net margin of -45.89%. Merit Medical Systems's return on equity of 9.19% beat Masimo's return on equity of -39.91%.

Merit Medical Systems has a consensus price target of $108.55, signalling upside risk potential of 16.09%. On the other hand Masimo has an analysts' consensus of $183.74 which suggests that it could grow by 9.23%. Given that Merit Medical Systems has higher upside potential than Masimo, analysts believe Merit Medical Systems is more attractive than Masimo.

Merit Medical Systems has a beta of 0.662, which suggesting that the stock is 33.793% less volatile than S&P 500. In comparison Masimo has a beta of 1.187, suggesting its more volatile than the S&P 500 by 18.725%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Masimo quarterly revenues of $372M. Merit Medical Systems's net income of $30.1M is higher than Masimo's net income of -$170.7M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.83x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.04x versus 4.62x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.